Abstract: The present disclosure provides a method for continuously and efficiently preparing taurine, including:(a) bringing an ethylene oxide with an alkali metal bisulfite into an addition reaction to obtain an alkali metal isethionate; (b) bringing the alkali metal isethionate with an ammonia into an ammonolysis reaction to obtain a solution containing alkali metal taurinate; and (c) inputting the solution containing alkali metal taurinate into at least one acid cation exchange resin column in activated state to obtain the taurine through an acidification treatment, followed by activating a portion of the at least one acid cation exchange resin column by a first activation manner using sulfurous acid and obtaining a solution containing alkali metal bisulfite, and activating another portion of the at least one acid cation exchange resin column by a second activation manner using sulfuric acid, wherein the first and second activation manner may be performed on a same acid cation exchange resin column alternatingly or

Abstract: Provided are ternary positive electrode material precursor and preparation method thereof, ternary positive electrode material, lithium-ion battery, positive electrode, and electric-involved equipment. The precursor includes, sequentially from inside to outside, core layer, first intermediate layer, second intermediate layer, and shell layer. Porosities of core layer, first intermediate layer, and second intermediate layer increase sequentially. Shell layer has the smallest porosity or no porosity. The method includes: performing first reaction of raw materials including nickel-cobalt-manganese ternary metal salt mixed solution, complexing agent, and pH modifier to obtain core layer; performing second reaction to form first intermediate layer on surface of core layer; performing third reaction to form second intermediate layer on surface of first intermediate layer; and performing fourth reaction to form shell layer on surface of second intermediate layer.

Abstract: The present disclosure provides a system for efficiently preparing taurine, including: a solution storage unit configured to store a solution containing alkali metal taurinate, the solution being prepared by an ethylene oxide process; an ion exchange unit including at least one ion exchange resin column each configured to be activated by a first activation manner or a second activation manner independently, the first activation manner using sulfurous acid for activation to obtain alkali metal bisulfate and taurine, and the second activation manner using sulfuric acid for activation to obtain alkali metal sulfate and taurine; and a dispensing unit connected to the solution storage unit and the ion exchange unit respectively, and configured to adjust an amount of a solution conveyed from the solution storage unit to each of the at least one ion exchange resin column in the ion exchange unit.

Abstract: The present disclosure provides a system for efficiently preparing taurine, including: a solution storage unit configured to store a solution containing alkali metal taurinate, the solution being prepared by an ethylene oxide process; an ion exchange unit including at least one ion exchange resin column each configured to be activated by a first activation manner or a second activation manner independently, the first activation manner using sulfurous acid for activation to obtain alkali metal bisulfate and taurine, and the second activation manner using sulfuric acid for activation to obtain alkali metal sulfate and taurine; and a dispensing unit connected to the solution storage unit and the ion exchange unit respectively, and configured to adjust an amount of a solution conveyed from the solution storage unit to each of the at least one ion exchange resin column in the ion exchange unit.

Abstract: The present invention relates to a use of haloid acid salt and sulfonate of a compound of formula I and a salt of the compound of formula I in preparation of medicament for preventing or treating diseases caused by thrombosis or embolism. The present invention provides acid addition salts, especially haloid acid and sulfonic acid addition salts of a compound of formula I having high inhibition effect on platelet aggregation, and preparation method of the same, a medicament comprising the same, and a use and/or method for preventing or treating diseases caused by thrombosis or embolism.

Abstract: The present invention relates to a use of haloid acid salt and sulfonate of a compound of formula I and a salt of the compound of formula I in preparation of medicament for preventing or treating diseases caused by thrombosis or embolism. The present invention provides acid addition salts, especially haloid acid and sulfonic acid addition salts of a compound of formula I having high inhibition effect on platelet aggregation, and preparation method of the same, a medicament comprising the same, and a use and/or method for preventing or treating diseases caused by thrombosis or embolism.

Abstract: A method for functional testing of a power device with an associated software control system includes referencing a dynamic linked library (DLL) file belonging to a software package via a method of a class; instantiating an object of the class in functional testing software; and including a call to the method of the object in the functional testing software, wherein the call to the method executes a function of the referenced DLL, such that the referenced DLL comprises an implementation of the class.